Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 0.00x is 100% below its estimated 5-year average of 0.60x, near the low end of its estimated 5-year range (0.00x–10.26x).
As of 2026-10-06T16:37:35.049Z. 100.00% below its estimated 12-month average of 0.29x.
Calculation as of: 2026-10-06T16:37:35.049Z.
Quote observation: 2026-10-06T16:34:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c2239cca652f31aeacf416f33e6d20b1e6c1b9088f917a2c9fa2f7c7bfc29848
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
0.00x
EV/SALES RATIO AVG TTM
0.29x
EV/SALES RATIO AVG 3Y
0.29x
EV/SALES RATIO AVG 5Y
0.60x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.23x
median of 486 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
InMed Pharmaceuticals Inc.
Market Cap
$7.31M
EV/Sales Ratio
0.00x
TTM Avg
0.29x
3Y Avg
0.29x
5Y Avg
0.60x
Market Cap
$7.16M
EV/Sales Ratio
N/A
TTM Avg
1044.91x
3Y Avg
1288.72x
5Y Avg
2112.32x
Market Cap
$7.00M
EV/Sales Ratio
22.51x
TTM Avg
19.77x
3Y Avg
15.30x
5Y Avg
133.58x
Market Cap
$6.94M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.31M | 0.00x | 0.29x | 0.29x | 0.60x |
| Skye Bioscience, Inc. (SKYE)vs › | $7.30M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | N/A | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.27M | N/A | 5.06x | 10.00x | 33.75x |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.25M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.16M | N/A | 1044.91x | 1288.72x | 2112.32x |
| Mangoceuticals, Inc. (MGRX)vs › | $7.00M | 22.51x | 19.77x | 15.30x | 133.58x |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.67M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $6.94M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.78M | 6.84x | 5.17x | 3.61x | 2.57x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 0.00x |
| 2026-10-02 | 0.00x |
| 2026-10-01 | 0.00x |
| 2026-09-30 | 0.00x |
| 2026-09-29 | 0.00x |
| 2026-09-28 | 0.00x |
| 2026-09-25 | 0.00x |
| 2026-09-24 | 0.00x |
| 2026-09-23 | 0.00x |
| 2026-09-22 | 0.00x |
| 2026-09-21 | 0.00x |
| 2026-09-18 | 0.00x |
| 2026-09-17 | 0.00x |
| 2026-09-16 | 0.00x |
| 2026-09-15 | 0.00x |
| 2026-09-14 | 0.00x |
| 2026-09-11 | 0.00x |
| 2026-09-10 | 0.00x |
| 2026-09-09 | 0.14x |
| 2026-09-08 | 0.16x |
| 2026-09-04 | 0.21x |
| 2026-09-03 | 0.16x |
| 2026-09-02 | 0.18x |
| 2026-09-01 | 0.15x |
| 2026-08-31 | 0.18x |
| 2026-08-28 | 0.21x |
| 2026-08-27 | 0.26x |
| 2026-08-26 | 0.26x |
| 2026-08-25 | 0.27x |
| 2026-08-24 | 0.26x |
| 2026-08-21 | 0.29x |
| 2026-08-20 | 0.41x |
| 2026-08-19 | 0.42x |
| 2026-08-18 | 0.27x |
| 2026-08-17 | 0.29x |
| 2026-08-14 | 0.30x |
| 2026-08-13 | 0.26x |
| 2026-08-12 | 0.27x |
| 2026-08-11 | 0.29x |
| 2026-08-10 | 0.24x |
| 2026-08-07 | 0.30x |
| 2026-08-06 | 0.26x |
| 2026-08-05 | 0.23x |
| 2026-08-04 | 0.32x |
| 2026-08-03 | 0.29x |
| 2026-07-31 | 0.30x |
| 2026-07-30 | 0.33x |
| 2026-07-29 | 0.50x |
| 2026-07-28 | 0.50x |
| 2026-07-27 | 0.47x |
| 2026-07-24 | 0.54x |
| 2026-07-23 | 0.68x |
| 2026-07-22 | 0.49x |
| 2026-07-21 | 0.37x |
| 2026-07-20 | 0.35x |
| 2026-07-17 | 0.35x |
| 2026-07-16 | 0.42x |
| 2026-07-15 | 0.42x |
| 2026-07-14 | 0.39x |
| 2026-07-13 | 0.40x |
| 2026-07-10 | 0.47x |
| 2026-07-09 | 0.49x |
| 2026-07-08 | 0.48x |
| 2026-07-07 | 0.50x |
| 2026-07-06 | 0.44x |
| 2026-07-02 | 0.39x |
| 2026-07-01 | 0.42x |
| 2026-06-30 | 0.38x |
| 2026-06-29 | 0.40x |
| 2026-06-26 | 0.37x |
| 2026-06-25 | 0.34x |
| 2026-06-24 | 0.38x |
| 2026-06-23 | 0.33x |
| 2026-06-22 | 0.33x |
| 2026-06-18 | 0.32x |
| 2026-06-17 | 0.32x |
| 2026-06-16 | 0.31x |
| 2026-06-15 | 0.34x |
| 2026-06-12 | 0.34x |
| 2026-06-11 | 0.41x |
| 2026-06-10 | 0.34x |
| 2026-06-09 | 0.36x |
| 2026-06-08 | 0.37x |
| 2026-06-05 | 0.41x |
| 2026-06-04 | 0.39x |
| 2026-06-03 | 0.42x |
| 2026-06-02 | 0.35x |
| 2026-06-01 | 0.39x |
| 2026-05-29 | 0.40x |
| 2026-05-28 | 0.51x |
| 2026-05-27 | 0.49x |
| 2026-05-26 | 0.55x |
| 2026-05-22 | 0.55x |
| 2026-05-21 | 0.56x |
| 2026-05-20 | 0.44x |
| 2026-05-19 | 0.43x |
| 2022-09-14 | 0.02x |
| 2022-09-13 | 0.95x |
| 2022-09-12 | 6.85x |
| 2022-09-09 | 0.03x |
| 2022-07-12 | 0.28x |
| 2022-07-11 | 0.35x |
| 2022-07-08 | 1.01x |
| 2022-07-07 | 1.31x |
| 2022-07-06 | 1.11x |
| 2022-07-05 | 1.11x |
| 2022-07-01 | 0.67x |
| 2022-06-30 | 0.67x |
| 2022-06-29 | 1.11x |
| 2022-06-28 | 1.01x |
| 2022-06-27 | 1.11x |
| 2022-06-24 | 1.11x |
| 2022-06-23 | 1.11x |
| 2022-06-22 | 1.07x |
| 2022-06-21 | 2.21x |
| 2022-06-17 | 2.03x |
| 2022-06-16 | 2.02x |
| 2022-06-15 | 1.81x |
| 2022-06-14 | 2.76x |
| 2022-06-13 | 3.13x |
| 2022-06-10 | 4.58x |
| 2022-06-09 | 4.84x |
| 2022-06-08 | 4.74x |
| 2022-06-07 | 5.18x |
| 2022-06-06 | 5.28x |
| 2022-06-03 | 5.28x |
| 2022-06-02 | 5.72x |
| 2022-06-01 | 6.71x |
| 2022-05-31 | 7.26x |
| 2022-05-27 | 7.90x |
| 2022-05-26 | 7.92x |
| 2022-05-25 | 7.04x |
| 2022-05-24 | 7.04x |
| 2022-05-23 | 7.70x |
| 2022-05-20 | 7.30x |
| 2022-05-19 | 7.70x |
| 2022-05-18 | 7.48x |
| 2022-05-17 | 8.57x |
| 2022-05-16 | 7.92x |
| 2022-05-04 | 1.39x |
| 2022-05-03 | 2.82x |
| 2022-05-02 | 4.48x |
| 2022-04-21 | 1.58x |
| 2022-04-20 | 0.56x |
| 2022-04-19 | 1.17x |
| 2022-04-04 | 0.76x |
| 2022-03-31 | 0.06x |
| 2022-03-29 | 4.06x |
| 2022-03-28 | 2.41x |
| 2022-03-25 | 7.37x |
| 2022-03-24 | 4.48x |
| 2022-02-28 | 0.01x |
| 2022-02-25 | 2.82x |
| 2022-02-24 | 3.24x |
| 2022-02-23 | 2.82x |
| 2022-02-22 | 2.82x |
| 2022-02-18 | 4.48x |
| 2022-02-17 | 7.37x |
| 2022-02-16 | 10.26x |
| 2022-02-15 | 9.02x |
